Potential risk factors for infection with Candida spp. in critically ill patients

被引:68
作者
Peres-Bota, D
Rodriguez-Villalobos, H
Dimopoulos, G
Melot, C
Vincent, JL
机构
[1] Free Univ Brussels, Erasme Hosp, Dept Intens Care, B-1050 Brussels, Belgium
[2] Free Univ Brussels, Erasme Hosp, Dept Bacteriol, B-1050 Brussels, Belgium
关键词
antifungal resistance; antifungal therapy; Candida; infection; mortality;
D O I
10.1111/j.1469-0691.2004.00873.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The incidence, risk factors and prognostic factors for candidal infection were determined in a prospective study of 280 infected patients. Thirty-one (11%) patients were infected with Candida spp., sub-divided into 18 (58%) with C. albicans, and 13 (42%) with non-albicans spp. (six C. glabrata, three C. parapsilosis, and one each of C. krusei, C. tropicalis, C. guilliermondii and C. lusitaniae). Infection with Candida spp. was always associated with concurrent bacterial infection. By univariate logistic regression analysis, the degree of morbidity and the duration of mechanical ventilation were independent predictive factors for death, but infection with Candida spp., was not. Factors associated with Candida spp. infection were the degree of morbidity, intensive care unit length of stay, alterations of immune response, and the number of medical devices involved. By multivariate logistic regression analysis, the only independent risk factor for candidal infection was intensive care unit length of stay.
引用
收藏
页码:550 / 555
页数:6
相关论文
共 34 条
[1]  
[Anonymous], CURR OPIN CRIT CARE
[2]  
BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
[3]   Outcome in critically ill patients with candidal fungaemia:: Candida albicans vs. Candida glabrata [J].
Blot, S ;
Vandewoude, K ;
Hoste, E ;
Poelaert, J ;
Colardyn, F .
JOURNAL OF HOSPITAL INFECTION, 2001, 47 (04) :308-313
[4]   Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study [J].
Blumberg, HM ;
Jarvis, WR ;
Soucie, JM ;
Edwards, JE ;
Patterson, JE ;
Pfaller, MA ;
Rangel-Frausto, MS ;
Rinaldi, MG ;
Saiman, L ;
Wiblin, RT ;
Wenzel, RP .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (02) :177-186
[5]   Comparison between procalcitonin, serum amyloid A, and C-reactive protein as markers of serious bacterial and fungal infections after solid organ transplantation [J].
Cooper, D ;
Sharples, L ;
Cornelissen, J ;
Wallwork, J ;
Alexander, G ;
Trull, A .
TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) :1808-1810
[6]  
Diamond R D, 1989, Rev Infect Dis, V11 Suppl 7, pS1600
[7]   Fungal infection in the intensive care unit [J].
Flanagan, PG ;
Barnes, RA .
JOURNAL OF HOSPITAL INFECTION, 1998, 38 (03) :163-177
[8]   CANDIDEMIA IN A TERTIARY CARE HOSPITAL - EPIDEMIOLOGY, RISK-FACTORS, AND PREDICTORS OF MORTALITY [J].
FRASER, VJ ;
JONES, M ;
DUNKEL, J ;
STORFER, S ;
MEDOFF, G ;
DUNAGAN, WC .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (03) :414-421
[9]   CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140
[10]  
Gleason TG, 1997, ARCH SURG-CHICAGO, V132, P1197, DOI 10.1001/archsurg.1997.01430350047008